Trexquant Investment’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-7,370
Closed -$1.2M 1494
2024
Q2
$1.2M Buy
+7,370
New +$1.05M 0.02% 936
2023
Q3
Sell
-5,161
Closed -$2.24M 1418
2023
Q2
$2.24M Sell
5,161
-3,785
-42% -$2.13M 0.06% 455
2023
Q1
$5.31M Buy
+8,946
New +$5.01M 0.15% 178
2022
Q4
Sell
-2,157
Closed -$1.26M 1338
2022
Q3
$1.26M Buy
2,157
+27
+1% +$16.2K 0.04% 467
2022
Q2
$1.16M Sell
2,130
-2,400
-53% -$1.21M 0.05% 450
2022
Q1
$2.87M Buy
+4,530
New +$2.33M 0.13% 188

Other funds holding AGL

Trexquant Investment's AGL Position: Q3 2024 in Review

Trexquant Investment sold out of Agilon Health (AGL) in Q3 2024, closing a stake of 7,370 shares — an estimated $1.2M sold.

Trexquant Investment first reported a position in AGL in Q1 2022 and held it in 6 quarters. The position peaked at $5.31M in Q1 2023. 209 funds tracked by Wall St. Rank hold AGL as of Q3 2024.

  • Trexquant Investment reported no remaining Agilon Health position as of Q3 2024 after selling out during the quarter.
  • Trexquant Investment sold 7,370 Agilon Health shares in Q3 2024, an estimated $1.2M.
  • Trexquant Investment first reported a position in Agilon Health in Q1 2022 and held it in 6 quarters.
  • Trexquant Investment's Agilon Health position peaked at $5.31M in Q1 2023.
  • 209 funds tracked by Wall St. Rank held Agilon Health as of Q3 2024.

Based on Trexquant Investment's 13F filing for Q3 2024, filed 12 Nov 2024.